PreludeDx
PrivateLast Round
VC Round
Mar 22, 2022
Total Funding Raised
$3.51M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PreludeDx operates in Healthcare & Life Sciences and is based in Laguna Hills, California. Its latest recorded funding round was a VC Round in March 2022.
PreludeDx is a biotechnology company that develops and provides precision diagnostic tests for early-stage breast cancer.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreludeDx Comparables
Compare PreludeDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agendia | 88% | |
| Silbiotech, Inc. | 78% | |
| Hologic, Inc. | 78% |
For institutional investors. Book with your work email.
PreludeDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 22, 2022 | ||||
| Strategic | Jul 19, 2021 | ||||
| Grant | Jan 1, 2014 | ||||
| Series A | Jul 27, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PreludeDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Fjord Ventures | VC Round, Series A |
| Evidity Health Capital | VC Round |
| BlueStone Venture Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 6, 2026
AI/ML-based SaMD for breast cancer screening is in development.
- Jul 26, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
PreludeDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PreludeDx's valuation, stock price, and market status.
Is PreludeDx a public or private company?
PreludeDx is a private company.
What is the current stock price of PreludeDx?
PreludeDx is a private company, so its shares have no public market price. Caplight tracks PreludeDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PreludeDx worth (valuation)?
Valuation information for PreludeDx is not publicly available.
Can I buy PreludeDx stock?
PreludeDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PreludeDx's last funding round?
PreludeDx's most recent funding round was VC Round on March 22, 2022.
Who are the main investors in PreludeDx?
Key investors in PreludeDx include National Cancer Institute, Fjord Ventures, Evidity Health Capital.
Will PreludeDx IPO soon?
No public IPO plans have been announced for PreludeDx.
How can I track PreludeDx secondary market activity?
Caplight tracks bids, offers, and trades in PreludeDx's shares on secondary markets.